Back | Next |
home / stock / allr / allr message board
Subject | By | Source | When |
---|---|---|---|
Oh ok why is it showing | INFINITI | investorshub | 06/28/2023 3:47:52 PM |
No it wasnt | ghosttrader13 | investorshub | 06/28/2023 3:47:10 PM |
Wow 52wk high $85 | INFINITI | investorshub | 06/28/2023 2:47:55 PM |
Wow cheapies for real here | INFINITI | investorshub | 06/28/2023 2:47:00 PM |
Bottom cat bounce | INFINITI | investorshub | 06/28/2023 2:43:30 PM |
Was this $6 yesterday | INFINITI | investorshub | 06/28/2023 2:39:31 PM |
Wow what happened | Awl416 | investorshub | 06/28/2023 2:30:21 PM |
Winder how big of a crash we see | ghosttrader13 | investorshub | 06/26/2023 1:45:01 AM |
$ALLR : Now 0.26........... how about the call, HEY | makinezmoney | investorshub | 06/12/2023 6:44:11 PM |
$ALLR: Exccellent bullflag breakout here.. now 0.20 | makinezmoney | investorshub | 06/12/2023 6:32:18 PM |
https://www.barchart.com/stocks/quotes/allr/technical-chart?plot=CANDLE&volume=total&data=DO | surf1944 | investorshub | 06/12/2023 5:50:02 PM |
So news didnt do anything for us today | ghosttrader13 | investorshub | 05/30/2023 8:11:06 PM |
It's what I call an inside out RS | rjack18 | investorshub | 05/30/2023 7:01:24 PM |
Real big pushing for 20% red lol its over | ghosttrader13 | investorshub | 05/30/2023 12:39:58 PM |
They dropped a bombshell this morning https://investors.allarity.com/news/news-d | tradenride | investorshub | 05/30/2023 10:45:46 AM |
Not all RS plays are bad, I added premarket | tradenride | investorshub | 05/30/2023 10:35:49 AM |
omg glad I bail this falling knife with | RammageRaul | investorshub | 05/26/2023 9:35:02 PM |
shareholders meeting 20 june vote for R/S what | peterus | investorshub | 05/26/2023 9:26:39 PM |
Me too I was expecting a stronger bounce | RammageRaul | investorshub | 05/26/2023 9:23:29 PM |
glad i sold | peterus | investorshub | 05/26/2023 9:20:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Allarity Therapeutics Inc. Company Name:
ALLR Stock Symbol:
NASDAQ Market:
- Phase 2 Trial of Stenoparib Concluded Early due to Clear Clinical Benefits Achieved - On Track to Regain Compliance with All Nasdaq Listing Requirements - No Variable Priced Securities are Outstanding - Warrant Overhang Near Elimination - Allarity Withdraws its F...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
- Conversions Eliminate All Variable Priced Derivative Securities - Conversions Eliminate Any Market Overhang from Warrants - Series A Preferred and Warrant Conversions were Investor Initiated - Limited Number of Warrants Convertible at $20 Per Share Remain - Compa...